Pannónia Magánorvosi Centrum Kft

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Ulcerative colitis4 trials
• Crohn's disease2 trials

Phase

• Phase 34 trials
• Phase 21 trial

Status

• Completed3 trials
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• InDex Pharmaceuticals1 trial
• Janssen Research & Development, LLC1 trial
• Pfizer1 trial
• Polpharma Biologics S.A.1 trial
• Shire1 trial

Running trials

• Recruiting

  A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT07499232· Phase 3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Crohn's disease1 recruiting

Closed trials

• Completed

  A study in people with moderately to severely active ulcerative colitis to see how well an investigational treatment called PB016 works and how safe it is compared to a licensed treatment called Entyvio®.

  2022-502778-18-00· Phase 3· Polpharma Biologics S.A.· Source

• Terminated

  The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

  NCT04985968· Phase 3· InDex Pharmaceuticals· Source

• Completed

  Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis

  NCT04607837· Phase 2· Pfizer· Source

• Completed

  A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)

  NCT03283085· Phase 3· Shire· Source